RU2007132513A - Способ мониторинга инсулиновой терапии диабета - Google Patents

Способ мониторинга инсулиновой терапии диабета Download PDF

Info

Publication number
RU2007132513A
RU2007132513A RU2007132513/14A RU2007132513A RU2007132513A RU 2007132513 A RU2007132513 A RU 2007132513A RU 2007132513/14 A RU2007132513/14 A RU 2007132513/14A RU 2007132513 A RU2007132513 A RU 2007132513A RU 2007132513 A RU2007132513 A RU 2007132513A
Authority
RU
Russia
Prior art keywords
insulin
diabetes
monitoring
insulin therapy
therapy
Prior art date
Application number
RU2007132513/14A
Other languages
English (en)
Other versions
RU2368312C2 (ru
Inventor
Владимир Дмитриевич Чувашов (RU)
Владимир Дмитриевич Чувашов
Дмитрий Николаевич Борисов (RU)
Дмитрий Николаевич Борисов
Сергей Борисович Шустов (RU)
Сергей Борисович Шустов
Original Assignee
Владимир Дмитриевич Чувашов (RU)
Владимир Дмитриевич Чувашов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Владимир Дмитриевич Чувашов (RU), Владимир Дмитриевич Чувашов filed Critical Владимир Дмитриевич Чувашов (RU)
Priority to RU2007132513/14A priority Critical patent/RU2368312C2/ru
Priority to DE212008000064U priority patent/DE212008000064U1/de
Priority to PCT/RU2008/000577 priority patent/WO2009031943A1/ru
Publication of RU2007132513A publication Critical patent/RU2007132513A/ru
Application granted granted Critical
Publication of RU2368312C2 publication Critical patent/RU2368312C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A61M2005/1726—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure the body parameters being measured at, or proximate to, the infusion site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Primary Health Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Claims (5)

1. Способ мониторинга инсулиновой терапии диабета (варианты), основанный на оптических и/или электрохимических измерениях характеристик исследуемой, например, подкожной среды или цельной крови, отличающийся тем, что периодически вводят контрольные дозы (ультра) короткого инсулина в месте измерений и используют перепад в результатах измерений, возникающий после каждой импульсной дозы инсулина, для определения текущего уровня глюкозы на данном интервале измерений.
2. Способ мониторинга инсулиновой терапии диабета п.1, отличающийся тем, что
вводят инсулин с помощью инсулиновой помпы с программным управлением через канюлю, которую закрепляют пластырем на теле пациента, а рядом с местом ввода инъекций располагают чувствительные к глюкозе элементы измерений.
3. Способ мониторинга инсулиновой терапии диабета п.2, отличающийся тем, что
инсулин вводят через интрадермальный порт той или иной конструкции.
4. Способ мониторинга инсулиновой терапии диабета п.3, отличающийся тем, что
через интрадермальный порт в подкожную среду периодически погружают электрохимический датчик (электрод), чувствительный к глюкозе.
5. Способ мониторинга инсулиновой терапии диабета, отличающийся тем, что
в промежутках между измерениями производят помповую администрацию инсулина по назначению врача.
RU2007132513/14A 2007-08-28 2007-08-28 Способ мониторинга инсулиновой терапии диабета RU2368312C2 (ru)

Priority Applications (3)

Application Number Priority Date Filing Date Title
RU2007132513/14A RU2368312C2 (ru) 2007-08-28 2007-08-28 Способ мониторинга инсулиновой терапии диабета
DE212008000064U DE212008000064U1 (de) 2007-08-28 2008-08-25 Vorrichtung zur Überwachung der Diabetes-Insulin-Therapie
PCT/RU2008/000577 WO2009031943A1 (ru) 2007-08-28 2008-08-25 Способ мониторинга инсулиновой терапии диабета

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2007132513/14A RU2368312C2 (ru) 2007-08-28 2007-08-28 Способ мониторинга инсулиновой терапии диабета

Publications (2)

Publication Number Publication Date
RU2007132513A true RU2007132513A (ru) 2009-03-10
RU2368312C2 RU2368312C2 (ru) 2009-09-27

Family

ID=40429110

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007132513/14A RU2368312C2 (ru) 2007-08-28 2007-08-28 Способ мониторинга инсулиновой терапии диабета

Country Status (3)

Country Link
DE (1) DE212008000064U1 (ru)
RU (1) RU2368312C2 (ru)
WO (1) WO2009031943A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2538715C1 (ru) * 2013-11-19 2015-01-10 Ирина Георгиевна Данилова Способ оценки длительной гипергликемии

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI614024B (zh) * 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
ES2710250T3 (es) * 2012-08-24 2019-04-23 Hoffmann La Roche Bomba de insulina y métodos de funcionamiento de la bomba de insulina
US9314564B2 (en) * 2012-11-19 2016-04-19 Roche Diabetes Care, Inc. Pump controller that checks operational state of insulin pump for controlling the insulin pump
RU2605792C2 (ru) * 2015-06-29 2016-12-27 Владимир Иванович Лунев Устройство для компенсации гипергликемии у больных сахарным диабетом

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6097975A (en) 1998-05-13 2000-08-01 Biosensor, Inc. Apparatus and method for noninvasive glucose measurement
US6438397B1 (en) 1999-10-28 2002-08-20 Gerald G. Bosquet Method and apparatus for analyte detection using intradermally implanted skin port
RU2180514C1 (ru) * 2001-01-15 2002-03-20 ШМЕЛЕВ Владимир Михайлович Способ неинвазивного определения концентрации глюкозы

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2538715C1 (ru) * 2013-11-19 2015-01-10 Ирина Георгиевна Данилова Способ оценки длительной гипергликемии

Also Published As

Publication number Publication date
WO2009031943A1 (ru) 2009-03-12
RU2368312C2 (ru) 2009-09-27
DE212008000064U1 (de) 2010-09-23

Similar Documents

Publication Publication Date Title
ES2432404T3 (es) Método y dispositivo para medida de sustancias
US8303533B2 (en) Device and method for delivery of a physiologically active substance depending on a measured physiological parameter
US9320851B2 (en) Infusion arrangement and method
JP5624322B2 (ja) 生体内電気化学的分析対象物感知を伴った液体供給
US8317698B2 (en) Method of monitoring an automated point-of-care fluid testing system
ES2375891T3 (es) Dispositivo médico para la vigilancia o la regulación de glucosa.
US20120123230A1 (en) Analyte monitoring systems and methods of use
US20120046651A1 (en) Medical device for glucose monitoring or regulation
US20070191702A1 (en) Systems and methods for sensing analyte and dispensing therapeutic fluid
JP2008545460A (ja) 一体的な薬剤送達及び被分析物センサ器具
US20090312622A1 (en) Device And Method For Determining A Value Of A Physiological Parameter Of A Body Fluid
JP2011507556A5 (ru)
WO2018201931A1 (zh) 一种分析物监测与自动给药系统
RU2007132513A (ru) Способ мониторинга инсулиновой терапии диабета
CN110087713B (zh) 药剂输送装置
CN108209942B (zh) 一种无创连续血糖测量系统
US11617832B2 (en) Portal system-based bionic pancreas
Tamada et al. Glucose monitoring using electroosmotic transdermal extraction
EP2953666B1 (en) Infusion arrangement and method
US9950111B2 (en) Device for the transcutaneous, in vivo measurement of the concentration of at least one analyte in a living organism
US20230157598A1 (en) Glucose sensor
Fowler Diabetes devices.
Khalid et al. Advancement in Insulcagon pump simulating as an artificial pancreas for the treatment of diabetes
Shaked et al. In vitro and in vivo performance of a pre-filled, electrochemically-actuated infusion system
Zhu et al. Estimation of volume of fluid in the peritoneal cavity by bioimpedance analysis

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20110829